Related Experiment Videos
Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis
A Fogo1, E P Hawkins, P L Berry
1Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Insights
Pediatric patients who develop focal glomerular sclerosis (FGS) show larger glomerular tuft area (GA) on initial biopsies compared to minimal change disease (MCD) patients. This finding may aid in early diagnosis of FGS in children.
Area of Science:
- Nephrology
- Pediatric Pathology
- Diagnostic Biomarkers
Background:
- Minimal change disease (MCD) is a common cause of nephrotic syndrome in children.
- Distinguishing MCD from focal glomerular sclerosis (FGS) on initial biopsy can be challenging.
- Identifying early indicators for FGS progression in pediatric patients is crucial for prognosis.
Purpose of the Study:
- To identify a diagnostic clue in initial renal biopsies that predicts the subsequent development of focal glomerular sclerosis (FGS) in pediatric patients initially diagnosed with minimal change disease (MCD).
Main Methods:
- Morphometric analysis of initial renal biopsies from pediatric patients diagnosed with MCD.
- Comparison of mean glomerular tuft area (GA) between patients who later developed FGS and those with a sustained MCD course.
- Inclusion of age-matched autopsy controls and separate cohorts of adult and pediatric FGS patients for comparison.
Main Results:
- Pediatric patients who progressed from apparent MCD to FGS had a significantly larger mean glomerular tuft area (GA) on initial biopsy (13.5 x 10(-3) mm2) compared to those with persistent MCD (7.7 x 10(-3) mm2) and controls (8.4 x 10(-3) mm2).
- Adult and pediatric patients with initial FGS also exhibited significantly larger GA than control groups.
- A larger GA in initial biopsies may indicate a higher risk of developing FGS.
Conclusions:
- Glomerular tuft area (GA) on initial renal biopsy may serve as a predictive morphometric marker for identifying pediatric patients with apparent minimal change disease (MCD) who are at risk of progressing to focal glomerular sclerosis (FGS).
- This finding could improve diagnostic accuracy and guide clinical management for pediatric kidney diseases.
Abstract:
The study sought a diagnostic clue to identify the group of pediatric patients with apparent minimal change disease who subsequently develop focal glomerular sclerosis (FGS). Review of all renal biopsy material at our institutions identified 42 pediatric patients who met the standard criteria for minimal change disease (MCD) on initial biopsies. Of those, 10 deteriorated clinically and on rebiopsy showed focal glomerular sclerosis (FGS). The initial renal biopsies of these 10 patients were analyzed morphometrically to determine the mean glomerular tuft area (GA). The results were compared to those of the remaining 32 patients whose subsequent benign clinical course was consistent with MCD, and to randomly selected, age-matched autopsy controls without renal disease (CONT, N = 10). The mean age was comparable among the three groups studied. Separate groups of adult (N = 12) and pediatric (N = 18) patients with initial biopsies with FGS were also studied. The initial biopsy of pediatric patients who subsequently showed FGS (rebiopsy performed on average 3.3 years later) had an average GA of 13.5 x 10(-3) mm2, 76% larger than glomeruli from children with MCD (7.7 x 10(-3) mm2, P less than 0.0005) and 62% larger than CONT (8.4 x 10(-3) mm2, P less than 0.005). Patients with FGS on initial biopsy, whether adult or pediatric, also had significantly larger GA than the age-matched MCD or CONT groups. Evaluation of GA in all the 42 pediatric biopsies with initial MCD further showed that in 23 patients GA was equal to or smaller than the CONT average.(ABSTRACT TRUNCATED AT 250 WORDS)